Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada.
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.
BJOG. 2022 Aug;129(9):1512-1520. doi: 10.1111/1471-0528.17084. Epub 2022 Jan 13.
Women with a history of pre-eclampsia have an elevated lifetime risk of cardiovascular disease that may be partly attributed to an adverse cardiovascular risk factor profile, the etiology of which is unclear. Hypothesising that this adverse risk profile may begin to arise over time in the years before pregnancy, we sought to evaluate the pregravid changes over time in cardiovascular risk factors in women who go on to develop pre-eclampsia and those who do not.
Retrospective cohort study using population-based administrative databases.
Ontario, Canada.
All nulliparous women who had singleton pregnancies between January 2011 and December 2018.
All results for the following analytes between January 2008 and the start of pregnancy were identified: A1c, glucose, lipids, and transaminases. Mean values were compared between those with and without preeclampsia. The annual change for each analyte in the years before pregnancy was estimated using generalized estimating equations.
Preeclampsia.
The 156 278 women (of whom 3827 developed preeclampsia) had mean 4.0 ± 3.3 pregravid tests overall. The two most recent pregravid tests were performed at median 0.6 and 1.9 years before pregnancy, respectively. Women who developed pre-eclampsia had higher pregravid A1c, fasting glucose, random glucose, LDL-cholesterol, triglycerides, and ALT, and lower HDL-cholesterol, than their peers (all P < 0.0001). In the years before pregnancy, women who went on to develop pre-eclampsia had higher annual increases than their peers in triglycerides (13.8-fold higher; P = 0.0004) and random glucose (1.55-fold higher; P = 0.001), coupled with a greater annual decrease in HDL-cholesterol (9.7-fold higher; P = 0.002). During this time, fasting glucose increased in women who developed pre-eclampsia but decreased in their peers (P = 0.01).
In women who develop pre-eclampsia, an adverse cardiovascular risk factor profile evolves over time in the years before pregnancy.
In women who develop pre-eclampsia, an adverse CV risk factor profile evolves in the years before pregnancy.
有子痫前期病史的女性终生患心血管疾病的风险增加,这可能部分归因于心血管不良风险因素谱,其病因尚不清楚。我们假设这种不良风险谱可能在怀孕前数年开始出现,因此我们试图评估发生子痫前期和未发生子痫前期的女性在怀孕前的心血管风险因素随时间的变化。
基于人群的回顾性队列研究,使用基于人群的行政数据库。
加拿大安大略省。
2011 年 1 月至 2018 年 12 月期间,所有单胎妊娠的初产妇。
确定 2008 年 1 月至怀孕前的以下分析物的所有结果:A1c、葡萄糖、血脂和转氨酶。比较有和无子痫前期的患者的平均值。使用广义估计方程估计怀孕前几年每个分析物的年变化。
子痫前期。
156278 名女性(其中 3827 名发生子痫前期)总体上进行了 4.0±3.3 次妊娠前检查。最近的两次妊娠前检查分别在怀孕前 0.6 年和 1.9 年进行。发生子痫前期的女性的妊娠前 A1c、空腹血糖、随机血糖、LDL 胆固醇、甘油三酯和 ALT 水平较高,HDL 胆固醇水平较低(均 P <0.0001)。在怀孕前的几年中,发生子痫前期的女性的甘油三酯(高 13.8 倍;P=0.0004)和随机血糖(高 1.55 倍;P=0.001)的年增长率高于其同龄人,而 HDL 胆固醇的年增长率(高 9.7 倍;P=0.002)较低。在此期间,发生子痫前期的女性的空腹血糖增加,而其同龄人则降低(P=0.01)。
在发生子痫前期的女性中,不良心血管风险因素谱在怀孕前数年逐渐形成。
在发生子痫前期的女性中,怀孕前的心血管风险因素谱逐渐演变。